Positioning ustekinumab in moderate-to-severe ulcerative colitis: new kid on the block
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2020.1727437
Abstract: ABSTRACT Introduction: Ulcerative colitis (UC) is a chronic relapsing disorder of the colonic tract. Dysregulated innate and adaptive immune pathways contribute to intestinal inflammation in IBD, and cytokines, including IL-12 and IL-23, play a key… read more here.
Keywords: positioning ustekinumab; ustekinumab moderate; severe ulcerative; ulcerative colitis ... See more keywords